CRIS vs REG · rev $10.9M vs P/E 34, $12.93B cap
Curis Inc (CRIS) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Curis Inc (CRIS) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported CRIS revenue for 2024-12-31 was $10.9M. Net income was -$43.4M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CRIS currently screens at market cap $22.1M.
REG does not have a complete income-statement cache yet.
CRIS currently screens at market cap $22.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CRIS and REG stock pages for the full models.
Not investment advice.